» Authors » Kabelo Mokgalaboni

Kabelo Mokgalaboni

Explore the profile of Kabelo Mokgalaboni including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 271
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Mabhida S, Mchiza Z, Mokgalaboni K, Hanser S, Choshi J, Mokoena H, et al.
BMC Infect Dis . 2024 Feb; 24(1):160. PMID: 38308222
The pathological consequences of inflammation persist in people living with the human immunodeficiency virus (PLWH), regardless of the positive outcomes of highly active antiretroviral therapy (HAART). The current systematic review...
12.
Mashaba R, Phoswa W, Maimela E, Mokgalaboni K
BMJ Open . 2024 Jan; 14(1):e079209. PMID: 38262658
Introduction: Patients with diabetes mellitus (DM) often present with comorbidities such as hypertension, dyslipidaemia, insulin resistance, obesity and hyperglycaemia, which increases their risk of cardiovascular diseases (CVDs)-related mortality. Carotid intima-media...
13.
Strauss K, Phoswa W, Lebelo S, Modjadji P, Mokgalaboni K
Thromb Res . 2024 Jan; 234:101-112. PMID: 38211378
Method: A comprehensive search for evidence was made on PubMed and Scopus on May 06, 2023, following the Preferred Reporting Items for Systematic Review and Meta-analysis. Cochrane and Newcastle-Ottawa quality...
14.
MacGirlley R, Phoswa W, Mokgalaboni K
Nutrients . 2023 Nov; 15(21). PMID: 37960227
Background: Evidence from preclinical studies has found a correlation between the development of type 2 diabetes (T2D) and vitamin D deficiency. However, evidence from randomized controlled trials (RCTs) revealed inconclusive...
15.
Makukule A, Modjadji P, Thovhogi N, Mokgalaboni K, Kengne A
Healthcare (Basel) . 2023 Oct; 11(20). PMID: 37893857
Hypertension is a poorly controlled risk factor for cardiovascular disease in South Africa, particularly among patients receiving care in the public sector who are mostly from low socioeconomic backgrounds. This...
16.
Mkhwanazi T, Modjadji P, Mokgalaboni K, Madiba S, Roomaney R
Diseases . 2023 Oct; 11(4). PMID: 37873773
The growing burden of non-communicable diseases amidst the largest burden of HIV in South Africa leads to disease combinations of multimorbidity with the complexity of care. We conducted a cross-sectional...
17.
Phoswa W, Mokgalaboni K
Life (Basel) . 2023 Sep; 13(9). PMID: 37763234
The use of medicinal plants in the management of diabetes mellitus (DM) is extensively reported. However, there is still very limited information on the role of these plants as markers...
18.
Mokgalaboni K, Dlamini S, Phoswa W, Modjadji P, Lebelo S
Antioxidants (Basel) . 2023 Aug; 12(8). PMID: 37627561
Diabetes mellitus is recognized as the leading contributor to cardiovascular disease and associated mortality rates worldwide. Despite the use of pharmaceutical drugs to treat diabetes, its prevalence continues to rise...
19.
Modjadji P, Mokgalaboni K, Nonterah E, Lebelo S, Mchiza Z, Madiba S, et al.
Viruses . 2023 Jul; 15(7). PMID: 37515129
Antiretroviral therapy (ART) regimens have been shown to cause metabolic changes in people living with HIV (PLWH), predisposing them to cardiometabolic disease (CVMD). However, such evidence is less established in...
20.
Zwane J, Modjadji P, Madiba S, Moropeng L, Mokgalaboni K, Mphekgwana P, et al.
Int J Environ Res Public Health . 2023 May; 20(10). PMID: 37239611
The burden of diabetes continues to increase in South Africa and a significant number of diabetes patients present at public primary healthcare facilities with uncontrolled glucose. We conducted a facility-based...